Abstract: Provided is a display device capable of suppressing electric power consumption as well as displaying an image with excellent quality. A host control section (30) in accordance with an aspect of the present invention includes: an image determining section (35) for determining whether or not an image has a characteristic of causing flicker to be easily recognizable; and a driving changing section (36) for, in a case where it is determined that the image has the characteristic of causing flicker to be easily recognizable, determining that (i) a display of the image is to be refreshed at a first refresh rate during a first period and (ii) the display of the image is to be refreshed at a different second refresh rate during a second period.

Abstract: An image measurement device acquires a first measurement region and a second measurement region on an image, acquires distance information corresponding to the first measurement region and distance information corresponding to the second measurement region, and computes a distance between the two regions. In a case where the first measurement region is displaced on the image, the second measurement region is displaced on a contour or a plane on the image, and a distance between the first measurement region after the displacement and the second measurement region after the displacement is computed. Thereby, distance measurement is able to be performed over a wide range without a complicated operation in the image measurement device for measuring a distance between two regions by using an image.

Abstract: In its several embodiments, this invention discloses a pharmaceutical formulation comprising at least one antineoplastic agent or a pharmaceutically acceptable salt thereof, and at least one dissolution enhancing agent sufficient to substantially dissolve said at least one antineoplastic agent in at least one aqueous diluent, wherein said dissolution enhancing agent is urea, L-histidine, L-threonine, L-asparagine, L-serine, L-glutamine or mixtures thereof; a lyophilized powder comprising said pharmaceutical formulation, and articles of manufacture thereof.

Abstract: While executing a television viewing APP, an engine (112) performs another application. A degree-of-concentration determination unit (131) determines the frequency of operations for the application, and calculates the degree of concentration for the program on the basis of the type of the application and the determination result. When the degree of concentration is high, the presentation controller (140) displays an advertisement relevant to the program, on a display unit (150).

Abstract: A touch panel includes: a sensor unit that includes a plurality of drive electrodes and a plurality of sensor electrodes that intersect one another defining a sensing area, the sensing area being divided into a plurality of preset regions; a measurement unit that measures electrostatic capacitance of intersection capacitance at each intersection of the drive electrodes and the sensor electrodes by charging the intersection capacitance for a charging period that is prescribed by a control signal provided to the measurement unit; a region determination unit that determines to which one of the preset regions in the sensing area the intersection capacitances respectively belong; and a signal generation unit that generates the control signal such that a length of the prescribed charging period varies in accordance with a determination result of the region determination unit.

Abstract: In a touch panel module, speed up of reaction speed for an input operation, lower current consumption, and suppression of generation of heat in a sensor electrode are enhanced by attaining lower resistance of the sensor electrode.

Abstract: A light projection apparatus that can produce an elongate light projection pattern is provided. The light projection apparatus includes a fluorescent member which is excited with exciting light and a light projecting member which reflects or transmits the light emanating from the fluorescent member to project it outside. The fluorescent member includes an irradiated region which is irradiated with the exciting light, and the length of the irradiated region in a first direction is greater than its length in a second direction.

Abstract: Novel compounds of the structural formula (I) are activators of AMP-protein kinase and may be useful in the treatment, prevention and suppression of diseases mediated by the AMPK activated protein kinase. The compounds of the present invention may be useful in the treatment of Type 2 diabetes, hyperglycemia, metabolic syndrome, obesity, hypercholesterolemia, and hypertension.

Abstract: In a head lamp 1, relative positions of a laser light guide path in a tapered light guide section 20 and a parabolic mirror 5 are fixed. An optical fiber 10 and the tapered light guide section 20 are each provided so as to have a receiving end part where laser light is received and an emitting end part where laser light is emitted. The emitting end part of the optical fiber 10 is located near the receiving end part of the tapered light guide section 20.

Abstract: An image forming apparatus (100) includes a discharge section (210), a paper receiving tray (93), a first detecting section (211), a lever (220), a second detecting section (230) and a decision section (240). The first detecting section (211) is disposed in the discharge section (210), and detects a paper jam. The second detecting section (230) detects a swinging state of the lever (220) from a first position at which the lever (220) is not in the process of receiving an action of the paper sheet to a second position. The decision section (240) judges an occurrence factor in a paper jam to be a user-induced factor when the second detecting section (230) detects a state in which the lever is at the first position in a state where the first detecting section (211) detects the paper jam.

Abstract: In order to offer a power supply circuit that can minimize the drop in efficiency by reducing losses during voltage conversion, in an improved-power factor circuit, a control circuit performs a step-up operation in which a control signal for turning on a first switching element (Tr1) and switching a second switching element (Tr2) is output, and a step-down operation in which a control signal for turning off the second switching element (Tr2) and switching the first switching element (Tr1) is output.

Abstract: A setting device sets a print page to be clear-coated. When print data is obtained, the setting device displays a preview of a print page image represented by the print data (step S1040). The setting device further receives a designation for a print page image of which preview is displayed, and sets a print page corresponding to the print page image of which designation has been received as a print page to be clear-coated (step S1050).

Abstract: Provided is a positive electrode active material giving nonaqueous-electrolyte secondary batteries superior in cycle characteristics. The positive electrode active material according to the present invention includes a lithium-containing composite metal oxide having the composition represented by the following General Formula (1): LizFe1-xMxP1-ySiyO4??(1) (wherein M is at least one metal element selected from Zr, Sn, Y, and Al, 0.05<x<1, and 0.05<y<1), characterized in that: the positive electrode active material is in the single crystalline phase of the lithium-containing composite oxide represented by General Formula (1) when 1>z>0.9 to 0.75 or 0.25 to 0.1>z>0; the positive electrode active material has two crystalline phases of the lithium-containing composite oxides represented by the following General Formulae (2) and (3) when 0.9 to 0.75>z>0.25 to 0.1: LiaFe1-xMxP1-ySiyO4??(2) (wherein 0.75 to 0.9?a?1.00, 0.05<x<1, and 0.

Abstract: [Object] To implement wireless communication also with a communicating apparatus that is a limited band terminal capable of receiving only part of frequencies.

Abstract: The present invention relates to 6-5 membered fused pyridine ring compounds according to formula (I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and to their use in therapy. In particular, the present invention relates to the use of 6-5 membered fused pyridine ring compounds according to formula I in the treatment of Brutons Tyrosine Kinase (Btk) mediated disorders.

Abstract: This light modulation panel is provided with: a first substrate having comb electrodes disposed on a uniformly planar electrode with an insulating layer therebetween; a second substrate disposed opposite to the first substrate and provided with a uniformly planar electrode; a light modulation layer obtained by dispersing anisometric members in a medium; and formed between the substrates; and a circuit for changing the direction in which an electric field is applied, which changes the direction of an electric field applied to the light modulation layer.

Abstract: A sensor electrode (31) provided between an insulating substrate (21) and a counter electrode (27) is electrically connected to a grid-shaped metal bridge (35) via an insulating layer.

Abstract: An image forming apparatus to which a plurality of process cartridges has a safety switch for detecting opening and closing of a front cover, stroke switches for detecting positions of the process cartridges, a display portion and a speaker for notifying a state of the process cartridge, and a control portion. The control portion has a cartridge information notifying function for, when closing of the front cover is detected by the safety switch and the process cartridge is not detected by the stroke switch, notifying information of the process cartridge. Further, the control portion has a cartridge information notifying function for notifying first notification information for replacing the process cartridge, a cartridge moving function for moving the process cartridge by a moving portion, and a cartridge information notification cancelling function for cancelling notification of the first notification information.

Abstract: The present invention provides novel pyrimidine amines of formula I which are potent inhibitors of spleen tyrosine kinase, and are useful in the treatment and prevention of diseases mediated by said enzyme, such as asthma, COPD, rheumatoid arthritis and cancer.

Abstract: Provided is a liquid crystal display device reducing display unevenness and image sticking even though employing a PSA polymerization step in which monomers are added to a liquid crystal layer. The liquid crystal display device includes a pair of substrates, at least one of the substrates including an alignment film and a structure consisting of an organic insulating material; a polymer layer that is formed on the alignment film to control the alignment of liquid crystal molecules; and a liquid crystal layer containing a liquid crystal material, the layer being placed between the pair of substrates, wherein the polymer layer is formed by polymerization of one or more kinds of radical polymerizable monomers contained in the liquid crystal layer, and at least one kind of the radical polymerizable monomers includes a structure which generates radicals through self-cleavage reaction by light irradiation and two or more radical polymerizable groups.